论文信息 - Selective Escalation of Imatinib Therapy and Early Switching to Nilotinib In De Novo Chronic Phase CML Patients: Interim Results From the TIDEL-II Trial - 字舞流文

Selective Escalation of Imatinib Therapy and Early Switching to Nilotinib In De Novo Chronic Phase CML Patients: Interim Results From the TIDEL-II Trial

A. Schwarer | D. White | T. Hughes | S. Branford | A. Grigg | C. Slader | D. Yeung | M. Hertzberg | C. Arthur | D. Ross | C. Forsyth | D. Hiwase | M. Osborn | Y. Kwan | R. Filshie | S. Issa | A. Mills | Lauren Haswell | T. Hughes | D. White